Department of Physiology and Biophysics, Cardiorenal and Metabolic Diseases Research Center, Mississippi Center for Obesity Research, University of Mississippi Medical Center, Jackson, Mississippi, United States.
Laboratory of Renal Pathophysiology, Department of Internal Medicine, University of Sao Paulo, Sao Paulo, Brazil.
Am J Physiol Renal Physiol. 2024 Dec 1;327(6):F957-F966. doi: 10.1152/ajprenal.00158.2024. Epub 2024 Oct 3.
In the present study, we examined whether chronic intracerebroventricular (ICV) leptin administration protects against ischemia/reperfusion (I/R)-induced acute kidney injury (AKI). Twelve-week-old male rats were implanted with an ICV cannula into the right lateral ventricle, and 8-10 days after surgery, leptin (0.021 µg/h, = 8) or saline vehicle (0.5 µL/h, = 8) was infused via osmotic minipump connected to the ICV cannula for 12 days. On of leptin or vehicle infusion, rats were submitted to unilateral ischemia/reperfusion (UIR) by clamping the left pedicle for 30 min. To control for leptin-induced reductions in food intake, the vehicle-treated group was pair-fed (UIR-PF) to match the same amount of food consumed by leptin-treated (UIR-Leptin) rats. On the 12th day of leptin or vehicle infusion (fourth day after AKI), single-left kidney glomerular filtration rate (GFR) was measured, blood samples were collected to quantify white blood cells, and kidneys were collected for histological assessment of injury. UIR-Leptin-treated rats showed reduced right and left kidney weights (right: 1,040 ± 24 vs. 1,281 ± 36 mg; left: 1,127 ± 71 vs. 1,707 ± 45 mg, for UIR-Leptin and UIR-PF, respectively). ICV leptin infusion improved GFR (0.50 ± 0.06 vs. 0.13 ± 0.03 mL/min/g kidney wt) and reduced kidney injury scores. ICV leptin treatment also attenuated the reduction in circulating adiponectin levels that was observed in UIR-PF rats and increased the circulating white blood cells count compared with UIR-PF rats (16.3 ± 1.3 vs. 9.8 ± 0.6 k/µL). Therefore, we show that leptin, via its actions on the central nervous system, confers significant protection against major kidney dysfunction and injury in a model of ischemia/reperfusion-induced AKI. A major new finding of this study is that chronic activation of leptin receptors in the CNS markedly attenuates acute kidney injury and protects against severe renal dysfunction after ischemia/reperfusion, independently of leptin's anorexic effects.
在本研究中,我们研究了慢性侧脑室给予瘦素(leptin)是否可以预防缺血再灌注(ischemia/reperfusion,I/R)引起的急性肾损伤(acute kidney injury,AKI)。12 周龄雄性大鼠接受右侧侧脑室脑室内(intracerebroventricular,ICV)套管植入术,手术后 8-10 天,通过与 ICV 套管相连的渗透微型泵输注瘦素(0.021μg/h,n=8)或生理盐水载体(0.5μL/h,n=8)12 天。在输注瘦素或载体的第 12 天,通过夹闭左侧 pedicle 30min 对大鼠进行单侧 I/R。为了控制瘦素引起的食物摄入减少,载体处理组通过匹配瘦素处理(ischemia/reperfusion-Leptin)大鼠消耗的相同量的食物进行配对喂养(pair-fed,UIR-PF)。在输注瘦素或载体的第 12 天(AKI 后第四天),测量单侧肾脏肾小球滤过率(glomerular filtration rate,GFR),采集血液样本以量化白细胞,并收集肾脏进行损伤的组织学评估。I/R-Leptin 处理的大鼠右肾和左肾重量降低(右肾:1,040±24 比 1,281±36mg;左肾:1,127±71 比 1,707±45mg,分别为 I/R-Leptin 和 UIR-PF)。ICV 瘦素输注改善了 GFR(0.50±0.06 比 0.13±0.03mL/min/g 肾重)并减轻了肾脏损伤评分。ICV 瘦素治疗还减轻了 UIR-PF 大鼠中观察到的循环脂联素水平的降低,并增加了与 UIR-PF 大鼠相比的循环白细胞计数(16.3±1.3 比 9.8±0.6k/µL)。因此,我们表明,瘦素通过其对中枢神经系统的作用,在缺血再灌注诱导的 AKI 模型中对主要的肾功能障碍和损伤提供了显著的保护作用。本研究的一个主要新发现是,慢性激活中枢神经系统中的瘦素受体可显著减轻急性肾损伤,并在缺血再灌注后保护严重肾功能障碍,而不依赖于瘦素的厌食作用。